PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 297 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 9.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $971 | +15.5% | 31,641 | +50.8% | 0.08% | +4.2% |
Q2 2023 | $841 | +10.2% | 20,977 | +12.2% | 0.07% | 0.0% |
Q1 2023 | $763 | +37.5% | 18,694 | +30.0% | 0.07% | +12.5% |
Q4 2022 | $555 | -99.9% | 14,381 | +6.3% | 0.06% | -28.1% |
Q3 2022 | $720,000 | -3.7% | 13,529 | +5.5% | 0.09% | 0.0% |
Q2 2022 | $748,000 | -23.0% | 12,827 | +0.7% | 0.09% | -13.6% |
Q1 2022 | $972,000 | +28.6% | 12,742 | +1.4% | 0.10% | +24.1% |
Q4 2021 | $756,000 | +99.5% | 12,564 | +85.7% | 0.08% | +48.2% |
Q3 2021 | $379,000 | – | 6,766 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |